Format

Send to

Choose Destination
Proteomes. 2016;4(4). pii: 29. Epub 2016 Oct 1.

Personalized Proteomics: The Future of Precision Medicine.

Author information

1
Department of Biological Sciences, University of Texas at El Paso, El Paso, TX 79968, USA.

Abstract

Medical diagnostics and treatment has advanced from a one size fits all science to treatment of the patient as a unique individual. Currently, this is limited solely to genetic analysis. However, epigenetic, transcriptional, proteomic, posttranslational modifications, metabolic, and environmental factors influence a patient's response to disease and treatment. As more analytical and diagnostic techniques are incorporated into medical practice, the personalized medicine initiative transitions to precision medicine giving a holistic view of the patient's condition. The high accuracy and sensitivity of mass spectrometric analysis of proteomes is well suited for the incorporation of proteomics into precision medicine. This review begins with an overview of the advance to precision medicine and the current state of the art in technology and instrumentation for mass spectrometry analysis. Thereafter, it focuses on the benefits and potential uses for personalized proteomic analysis in the diagnostic and treatment of individual patients. In conclusion, it calls for a synthesis between basic science and clinical researchers with practicing clinicians to design proteomic studies to generate meaningful and applicable translational medicine. As clinical proteomics is just beginning to come out of its infancy, this overview is provided for the new initiate.

KEYWORDS:

biomarker; clinical proteomics; diagnostic; mass spectrometry; personalized medicine; pharmacokinetics; precision medicine; proteomics; therapeutic monitoring

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center